AbbVie (ABBV) r&d spend was $9.1B in FY2025 (-29% YoY). The tables below show the complete quarterly and annual r&d spend history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual R&D Spend
Fiscal Year
R&D Spend
YoY
2025
$9.1B
-29%
2024
$12.8B
+67%
2023
$7.7B
+18%
2022
$6.5B
-6%
2021
$6.9B
+9%
2020
$6.4B
-0%
2019
$6.4B
-38%
2018
$10.3B
+106%
2017
$5.0B
+14%
2016
$4.4B
+2%
2015
$4.3B
+30%
2014
$3.3B
+15%
2013
$2.9B
+3%
2012
$2.8B
+6%
2011
$2.6B
Recent Quarterly R&D Spend
Quarter
R&D Spend
Q2 2026
$2.3B
Q1 2026
$2.5B
Q4 2025
$2.6B
Q3 2025
$2.3B
Q2 2025
$2.1B
Q1 2025
$2.1B
Q4 2024
$6.8B
Q3 2024
$2.1B
Q2 2024
$1.9B
Q1 2024
$1.9B
Q4 2023
$1.9B
Q3 2023
$1.7B
Source: ABBV on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.